640
Views
20
CrossRef citations to date
0
Altmetric
Review

Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections

, , , , , , , , , , & show all
Pages 731-746 | Received 25 Feb 2016, Accepted 27 Jun 2016, Published online: 15 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jamie John, Angela Loo, Shawn Mazur & Thomas J. Walsh. (2019) Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients. Expert Opinion on Drug Metabolism & Toxicology 15:11, pages 881-895.
Read now
Poonam Giri, Prashant Delvadia, Lakshmikant Gupta, Priyal Trivedi, Nirmal Patel, Manoranjan Sharma, Jaideep Singh, Abhijit Chatterjee, Shekhar Kadam & Nuggehally R. Srinivas. (2019) Impact of collagen-induced arthritis on the pharmacokinetic disposition of voriconazole, a widely used antifungal agent: in vitro and in vivo investigations in DBA/1J mice. Xenobiotica 49:6, pages 698-707.
Read now

Articles from other publishers (18)

Theresa Pecho & Markus Zeitlinger. (2023) Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A Review. Clinical Pharmacokinetics.
Crossref
Alba Alonso Llorente, Josefa Salgado Garrido, Oscar Teijido Hermida, Fabricio González Andrade, Alberto Valiente Martín, Ana Fanlo Villacampa & Jorge Vicente Romero. (2023) The Correlation of Two Different Real-Time PCR Devices for the Analysis of CYP2C19 Pharmacogenetic Results. Scientia Pharmaceutica 91:4, pages 51.
Crossref
Haotian Yang, Runxuan Du, Xiaoqing Xing, Ying Li & Bo Qiu. (2023) Efficacy and influencing factor analysis of Voriconazole in the treatment of invasive fungal infections. Diagnostic Microbiology and Infectious Disease 107:3, pages 116047.
Crossref
Guolin Li, Qinhui Li, Changji Zhang, Qin Yu, Qi Li, Xiaoshi Zhou, Rou Yang, Xuerong Yang, Hailin Liu & Yong Yang. (2023) The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals. Frontiers in Genetics 14.
Crossref
Stavros Tsotsolis, Serafeim-Chrysovalantis Kotoulas & Athina Lavrentieva. (2023) Invasive Pulmonary Aspergillosis in Coronavirus Disease 2019 Patients Lights and Shadows in the Current Landscape. Advances in Respiratory Medicine 91:3, pages 185-202.
Crossref
Laís de Almeida Campos, Margani Taise Fin, Kelvin Sousa Santos, Marcos William de Lima Gualque, Ana Karla Lima Freire Cabral, Najeh Maissar Khalil, Ana Marisa Fusco-Almeida, Rubiana Mara Mainardes & Maria José Soares Mendes-Giannini. (2023) Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections. Pharmaceutics 15:1, pages 266.
Crossref
Aadith Ashok, Rekha Pai Mangalore & C. Orla Morrissey. (2022) Azole Therapeutic Drug Monitoring and its Use in the Management of Invasive Fungal Disease. Current Fungal Infection Reports 16:2, pages 55-69.
Crossref
Maggie M. Chau, Kathryn Daveson, Jan‐Willem C. Alffenaar, Amanda Gwee, Su Ann Ho, Deborah J. E. Marriott, Jason A. Trubiano, Jessie Zhao & Jason A. Roberts. (2021) Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021. Internal Medicine Journal 51:S7, pages 37-66.
Crossref
José María Valle-T-Figueras, Berta Renedo Miró, Maria Isabel Benítez Carabante, Cristina Díaz-de-Heredia, Jaume Vima Bofarull, Natalia Mendoza-Palomar, Maria Teresa Martín-Gómez & Pere Soler-Palacín. (2021) Voriconazole Use in Children: Therapeutic Drug Monitoring and Control of Inflammation as Key Points for Optimal Treatment. Journal of Fungi 7:6, pages 456.
Crossref
Houli Li, Di Zhang, Xiaoliang Cheng, Marwa Fath Abdulqawi Sultan, Lilong Xiong, Ying Ma, Maoyi Wang & Weiyi Feng. (2021) Application of the Westgard Multi-rule Theory to Internal Quality Control Evaluation of Voriconazole for Therapeutic Drug Monitoring. Current Pharmaceutical Analysis 17:2, pages 265-272.
Crossref
Sara Blanco Dorado, Olalla Maroñas Amigo, Ana Latorre‐Pellicer, María Teresa Rodríguez Jato, Ana López‐Vizcaíno, Aurea Gómez Márquez, Belén Bardán García, Dolores Belles Medall, Gema Barbeito Castiñeiras, María Luisa Pérez del Molino Bernal, Manuel Campos‐Toimil, Francisco Otero Espinar, Andrés Blanco Hortas, Irene Zarra Ferro, Ángel Carracedo, María Jesús Lamas & Anxo Fernández‐Ferreiro. (2020) A multicentre prospective study evaluating the impact of proton‐pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations. British Journal of Clinical Pharmacology 86:8, pages 1661-1666.
Crossref
A. Warris, T. Lehrnbecher, E. Roilides, E. Castagnola, R.J.M. Brüggemann & A.H. Groll. (2019) ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clinical Microbiology and Infection 25:9, pages 1096-1113.
Crossref
Samyr M. Querobino, Naially C. de Faria, Aryane A. Vigato, Bruna G.M. da Silva, Ian P. Machado, Maricilia S. Costa, Fanny N. Costa, Daniele R. de Araujo & Carlos Alberto-Silva. (2019) Sodium alginate in oil-poloxamer organogels for intravaginal drug delivery: Influence on structural parameters, drug release mechanisms, cytotoxicity and in vitro antifungal activity. Materials Science and Engineering: C 99, pages 1350-1361.
Crossref
Jingxiang Zhang, Liping Li, Quanzhen Lv, Lan Yan, Yan Wang & Yuanying Jiang. (2019) The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors. Frontiers in Microbiology 10.
Crossref
Pier Giorgio Cojutti, Maria Merelli, Lorenzo Allegri, Giuseppe Damante, Matteo Bassetti & Federico Pea. (2018) Successful and safe long‐term treatment of cerebral aspergillosis with high‐dose voriconazole guided by therapeutic drug monitoring. British Journal of Clinical Pharmacology 85:1, pages 266-269.
Crossref
Nicholas Bennett, Paul J Maglione, Benjamin L Wright & Christa Zerbe. (2018) Infectious Complications in Patients With Chronic Granulomatous Disease. Journal of the Pediatric Infectious Diseases Society 7:suppl_1, pages S12-S17.
Crossref
Parisa Badiee, Zahra Hashemizadeh & Hashem Montaseri. (2017) Therapeutic Drug Monitoring of Voriconazole: Comparison of Bioassay with High-Performance Liquid Chromatography. Jundishapur Journal of Microbiology In press:In press.
Crossref
José Lobatón Ramírez, Auxiliadora Coronado Negrete, Rosangela Ramírez Barranco, Ernesto Rocha Reyes, Jean Carlos Pinto Angarita & Diana Borré Naranjo. (2016) Fusariosis diseminada por fusarium verticillioides en un paciente con leucemia mieloide aguda.. Revista Ciencias Biomédicas 7:2, pages 316-322.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.